Eulav Asset Management Integra Lifesciences Holdings Corp Transaction History

Eulav Asset Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$42.97 - $57.33 $575,798 - $768,222	-13,400 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$42.62 - $64.51 $106,550 - $161,275	-2,500 Reduced 15.72%	13,400 $604,000
Q1 2018 May 09, 2018	BUY	$46.55 - $57.38 $740,145 - $912,342	15,900 New	15,900 $880,000

294

69.9M

20.2K

9.3K

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $2.44B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

Stay updated on Eulav Asset Management with notifications on news.